---
title: "Narmada Gelatines Ltd (526739) — Share Price, Financials & Analysis"
symbol: "526739"
company: "Narmada Gelatines Ltd"
canonical: "https://tapetide.com/stocks/526739"
isin: "INE869A01010"
nse_symbol: "NARMADAGELATINESLTD"
bse_code: "526739"
sector: "Chemicals"
industry: "Specialty Chemicals"
market_cap_cr: 282.52
generated_at: "2026-09-13T18:38:13.128Z"
---

# Narmada Gelatines Ltd (526739)

Canonical page: https://tapetide.com/stocks/526739

## Company

- **NSE Symbol:** NARMADAGELATINESLTD
- **BSE Code:** 526739
- **ISIN:** INE869A01010
- **Sector:** Chemicals
- **Industry:** Specialty Chemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **CEO:** Mr. Ashok Kumar Kapur B.E.
- **Employees:** 198
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** narmadagelatines.com

## About

Incorporated in 1969, Narmada Gelatines Ltd manufactures and sells Gelatine and Ossein[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:40:00.124570Z.

- **Market Cap:** ₹282.52 Cr
- **Classification:** Microcap
- **P/E (reported):** 8.2
- **EPS (TTM):** ₹52.32
- **EPS (reported):** ₹23.8
- **Book Value:** ₹240.09
- **Price to Book:** 1.97
- **Dividend Yield:** 2.32%
- **ROE:** 21.68%
- **ROCE:** 27.22%
- **Debt to Equity:** 0.06
- **Revenue (yearly):** ₹215.7 Cr
- **Net Income:** ₹31.5 Cr
- **EBITDA:** ₹41.6 Cr
- **52-Week High:** ₹545
- **52-Week Low:** ₹327.3
- **RSI (14):** 46.76

## Tapetide Score

- **Score:** 69 / 100
- **Score date:** 2026-09-04
- **Archetype:** Quality at a Reasonable Price
- **What it means:** Financial strength is not being paid for with a demanding multiple. The question worth asking is whether the quality is durable or reflects a good patch — check the consistency of returns over several years rather than the latest quarter.
- **Pillar profile:** Quality: Good · Valuation: Cheap · Momentum: Rising
- **Percentile:** 99.3 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 87.43 | 9% |
| growth | 59.46 | 9% |
| momentum | 86.96 | 12% |
| ownership | 50 | 24% |
| quality | 73.01 | 22% |
| valuation | 69.76 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 38.6% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 32.0%

### Weaknesses

- The company has delivered a poor sales growth of 9.82% over past five years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 52.74% | 767.39% | 789.89% |
| ebitda margin growth | -10.34% | 40.12% | — | — |
| net income growth | -8.82% | 75% | 26% | 39% |
| revenue growth | -7.84% | 13.17% | 4% | 10% |
| roce | -10.07% | 43.19% | — | — |
| roe | -8.62% | 44.63% | — | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 41.59 | 47.08 | 49.47 | 43.22 | 47.91 | 48.02 | 49.77 | 45.77 | 51.21 | 56.73 | 61.7 | 56.37 |
| Expenses | 37.71 | 42.38 | 42.85 | 37.93 | 42.68 | 41.44 | 42.29 | 38.25 | 41.86 | 46.06 | 47.94 | 44.65 |
| Operating Profit | 3.88 | 4.7 | 6.62 | 5.29 | 5.23 | 6.58 | 7.48 | 7.52 | 9.35 | 10.67 | 13.76 | 11.72 |
| OPM % | 9.33 | 9.98 | 13.38 | 12.24 | 10.92 | 13.7 | 15.03 | 16.43 | 18.26 | 18.81 | 22.3 | 20.79 |
| Other Income | 0.39 | 0.45 | 0.5 | 0.56 | 0.77 | 0.29 | 0.03 | 0.04 | 0.55 | 0.05 | 0.14 | 0.14 |
| Interest | 0.09 | 0.05 | 0.03 | 0.03 | 0.27 | 0.55 | 0.36 | 0.24 | 0.2 | 0.29 | 0.29 | 0.15 |
| Depreciation | 0.51 | 0.51 | 0.52 | 0.52 | 0.59 | 0.56 | 0.55 | 0.65 | 0.65 | 0.65 | 0.92 | 0.76 |
| Profit before tax | 3.67 | 4.59 | 6.57 | 5.3 | 5.14 | 5.76 | 6.6 | 6.67 | 9.05 | 9.78 | 12.69 | 10.95 |
| Tax % | 27.25 | 25.49 | 25.27 | 24.53 | 25.49 | 25.69 | 18.79 | 25.34 | 28.4 | 24.34 | 24.51 | 25.21 |
| Net Profit | 2.67 | 3.42 | 4.91 | 4 | 3.83 | 4.28 | 5.36 | 4.98 | 6.48 | 7.4 | 9.58 | 8.19 |
| EPS in Rs | 4.41 | 5.65 | 8.12 | 6.61 | 6.33 | 7.07 | 8.86 | 8.23 | 10.71 | 12.23 | 15.84 | 13.54 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 118 | 126 | 134 | 135 | 157 | 191 | 182 | 189 | 215 | 226 |
| Expenses | 112 | 116 | 120 | 127 | 143 | 171 | 161 | 164 | 174 | 181 |
| Operating Profit | 5 | 9 | 14 | 8 | 15 | 20 | 21 | 25 | 41 | 46 |
| OPM % | 4.6 | 7 | 11 | 6 | 9 | 10 | 12 | 13 | 19 | 20 |
| Other Income | 4 | 5 | 6 | 6 | 3 | 2 | 2 | 2 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 |
| Profit before tax | 8 | 13 | 18 | 11 | 15 | 20 | 21 | 23 | 38 | 42 |
| Tax % | 5 | 24 | 28 | 26 | 20 | 23 | 26 | 24 | 26 | — |
| Net Profit | 8 | 10 | 13 | 8 | 12 | 15 | 15 | 17 | 28 | 32 |
| EPS in Rs | 13.29 | 16.63 | 21.29 | 13.98 | 20.4 | 25.26 | 25.34 | 28.45 | 47.01 | 52.32 |
| Dividend Payout % | 30 | 60 | 47 | 72 | 49 | 396 | 39 | 35 | 21 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 112 | 118 | 125 | 130 | 133 | 139 | 88 | 103 | 113 | 135 |
| Borrowings | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 13 | 8 |
| Other Liabilities | 21 | 16 | 22 | 24 | 26 | 25 | 23 | 25 | 27 | 26 |
| Total Liabilities | 140 | 140 | 155 | 161 | 165 | 170 | 117 | 134 | 159 | 175 |
| Fixed Assets | 22 | 25 | 24 | 26 | 29 | 27 | 28 | 27 | 33 | 41 |
| CWIP | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 7 | 6 |
| Investments | 45 | 53 | 68 | 65 | 50 | 48 | 4 | 10 | 41 | 41 |
| Other Assets | 73 | 62 | 61 | 69 | 85 | 94 | 85 | 97 | 78 | 87 |
| Total Assets | 140 | 140 | 155 | 161 | 165 | 170 | 117 | 134 | 159 | 175 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 7 | 9 | 12 | 5 | 3 | 2 | 14 | 15 | 17 | 25 |
| Cash from Investing Activity | -2 | -2 | -5 | -4 | 6 | 10 | 44 | -12 | -29 | -13 |
| Cash from Financing Activity | -5 | -3 | -1 | -9 | -7 | -6 | -67 | 0 | 5 | -12 |
| Net Cash Flow | 0 | 4 | 6 | -8 | 2 | 6 | -9 | 2 | -6 | 0 |
| Free Cash Flow | 7 | 4 | 11 | 1 | 0 | 2 | 12 | 13 | 2 | 15 |
| CFO/OP | 246 | 208 | 152 | 58 | 96 | 42 | 101 | 90 | 92 | 79 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 52 | 59 | 56 | 55 | 48 | 36 | 37 | 44 | 48 | 49 |
| Inventory Days | 192 | 144 | 144 | 166 | 166 | 185 | 152 | 161 | 155 | 156 |
| Days Payable | 52 | 40 | 62 | 63 | 62 | 57 | 42 | 50 | 57 | 39 |
| Cash Conversion Cycle | 193 | 163 | 138 | 158 | 152 | 164 | 147 | 155 | 146 | 166 |
| Working Capital Days | 146 | 127 | 95 | 108 | 115 | 119 | 97 | 103 | 88 | 97 |
| ROCE % | 4 | 5 | 7 | 11 | 5 | 10 | 16 | 20 | 20 | 28 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 77.65% | 77.65% | 77.65% | 77.65% | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 19.03% | 19.02% | 18.44% | 18.66% | 21.09% | 21.34% | 21.65% | 21.91% | 21.93% | 21.86% | 21.82% | 21.88% |
| Others | 3.32% | 3.32% | 3.9% | 3.69% | 3.91% | 3.66% | 3.34% | 3.08% | 3.07% | 3.13% | 3.18% | 3.11% |
| No. of Shareholders | 7552 | 7569 | 7515 | 7378 | 7864 | 7547 | 7560 | 7615 | 7809 | 7559 | 7312 | 7723 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 5 / 6 / 8

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 464.48 | Sell |
| EMA (10) | 468.75 | Sell |
| SMA (20) | 474.05 | Sell |
| EMA (20) | 474.43 | Sell |
| SMA (50) | 491.28 | Sell |
| EMA (50) | 479.47 | Sell |
| SMA (100) | 470.47 | Sell |
| EMA (100) | 463.37 | Buy |
| SMA (200) | 412.79 | Buy |
| EMA (200) | 431.51 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 41.24 | Neutral |
| MACD (12,26,9) | -7.48 | Buy |
| Stochastic (14,3,3) | 46.55 | Neutral |
| ADX (14) | 28.07 | Buy |
| Williams %R (14) | -62.25 | Neutral |
| ATR (14) | 14.04 | High Volatility |
| ROC (12) | -2.63 | Sell |
| Stoch RSI (14) | 63.53 | Neutral |
| UO (7,14,28) | 46.34 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-21 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19b4cefc-d958-42bd-b8ed-d317e6760bba.pdf) |
| 2026-08-19 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e261215-d308-4f94-82fc-f6df556db609.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9f61b06-814d-4624-9bc0-191fb5d93daf.pdf) |
| 2026-08-12 | [Board Meeting Outcome for Outcomes Of The Board Meeting Held On 12Th August 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94703c6c-dcfe-4520-8b88-1be22ceb1a99.pdf) |
| 2026-08-01 | [Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Reg.29 Of SEBI (LODR) Regulation 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f9f7371-ffe5-493b-b4fb-8207a41aa385.pdf) |
| 2026-07-22 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9196ae43-43a9-4190-9710-d2e07d4ff14a.pdf) |
| 2026-07-22 | [Announcement Under Regulation 30 - Letters Sent To Shareholders](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e47f3dd9-52da-4d19-b5c9-b96a6887aa49.pdf) |
| 2026-07-21 | [Notice Of The 65Th Annual General Meeting Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=24041ed4-033a-48cd-b98e-97206aa00482.pdf) |
| 2026-07-21 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=637d4da7-1dca-423e-8a1e-77424365e775.pdf) |
| 2026-07-21 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e9f4b2a-a8d3-4654-b2b3-34f7e1d2b6ca.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-12 | [Un-Audited Financial Results For The Quarter Ended 30Th June 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cf6c3c0-786c-4f25-b2ad-b2f333cbd67b.pdf) |
| 2026-05-25 | [Audited Standalone And Consolidated Financial Results For The Quarter/Year Ended 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6322e65a-ebb1-4e2b-a757-cbf780513bd6.pdf) |
| 2026-02-12 | [Un-Audited Financial Results Of The Company For The Quarter Ended 31St December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f94c8a3a-2ca6-460f-a3f6-89bd70e0ef4b.pdf) |
| 2025-11-12 | [Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2320e0cf-18dd-4753-9e92-ae5e1d923873.pdf) |
| 2025-08-13 | [Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33402f2d-8be9-412c-8e34-2bbaa56b018c.pdf) |
| 2025-05-24 | [Audited Financial Results For The Quarter And Financial Year Ended 31St March 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52db0fac-6112-4f69-b1e0-aa98f0e44c04.pdf) |
| 2024-05-21 | [Results- For Quarter And Financial Year Ended 31.03.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9599e69-4086-4bcf-8a46-b57a204b11b9.pdf) |
| 2023-05-16 | [Board Meeting Outcome for Audited Standalone Financial Results For The Quarter And Year Ended March 31St, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=980fe50b-737c-4c62-9ac7-71dadc1b42f7.pdf) |
| 2023-05-16 | [Board Meeting Outcome for Audited Financial Results For The Year Ended 31St March 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e7e885d-710f-4ce3-a0e4-80c4a87cb0c1.pdf) |
| 2023-02-10 | [Financial Results For Quarter And Nine Months Ended 31St December, 2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4d19518-a3b6-4491-9d30-5ced39ea5363.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 7 Apr - Filed Regulation 74(5) certificate for quarter and year ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Apr - Filed Regulation 74(5) certificate for quarter and year ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/29764ac4-317f-4254-a2fb-042a771c3370.pdf) |
| 6 Mar - CARE Edge reaffirmed Narmada Gelatines' ratings: Term loan ₹31.35cr CARE BBB; Stable; CC ₹20.00cr CARE A3+ (06-Mar-2026) | [Announcement under Regulation 30 (LODR)-Credit Rating 6 Mar - CARE Edge reaffirmed Narmada Gelatines' ratings: Term loan ₹31.35cr CARE BBB; Stable; CC ₹20.00cr CARE A3+ (06-Mar-2026)](https://www.bseindia.com/xml-data/corpfiling/AttachHis/99a8438e-f169-404b-ab30-70068777e30b.pdf) |
| 4 Feb - Board meeting Feb 12, 2026 in Jabalpur to approve unaudited Q3 and nine-month results; trading window closed till Feb 14. | [Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015. 4 Feb - Board meeting Feb 12, 2026 in Jabalpur to approve unaudited Q3 and nine-month results; trading window closed till Feb 14.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9de06dd8-4a3c-4e8a-88a4-6b509dd7207f.pdf) |
| 2 Mar - SEBI opens Feb 5, 2026–Feb 4, 2027 window for transfer/demat of pre-April 1, 2019 securities; one-year lock-in. | [Opening Of Special Window For Transfer And Dematerialization Of Physical Securities 2 Mar - SEBI opens Feb 5, 2026–Feb 4, 2027 window for transfer/demat of pre-April 1, 2019 securities; one-year lock-in.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e4bbc2cf-4893-4710-ada3-9390642841d1.pdf) |
| 17 Jan - Report on re-lodgement of physical share transfer requests per SEBI circular dated July 2, 2025. | [Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares 17 Jan - Report on re-lodgement of physical share transfer requests per SEBI circular dated July 2, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/214d30d1-2cf3-464f-9780-c636470e9b48.pdf) |
| 13 Feb - Newspaper Advertisement - Disclosure under Regulation 30 and 47 of of SEBI (LODR) Regulations, 2015, extracts of Un-audited Financial Results for the quarter and nine … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 13 Feb - Newspaper Advertisement - Disclosure under Regulation 30 and 47 of of SEBI (LODR) Regulations, 2015, extracts of Un-audited Financial Results for the quarter and nine …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c014459e-0506-47c3-98a2-cb1b8ac827c1.pdf) |
| 12 Feb - Board approved unaudited standalone and consolidated Q3/9M results for period ended Dec 31, 2025; limited review attached. | [Board Meeting Outcome for Board Meeting Outcome For Approval Of Un-Audited Financial Results For The Quarter Ended 31St December, 2025. 12 Feb - Board approved unaudited standalone and consolidated Q3/9M results for period ended Dec 31, 2025; limited review attached.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4c9dba76-e2c9-42aa-9d9c-594315e57e69.pdf) |
| — | [Closure of Trading Window 25 Mar](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a8776cb7-af36-4685-8211-416ba249f031.pdf) |
| — | [Un-Audited Financial Results Of The Company For The Quarter Ended 31St December, 2025 12 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f94c8a3a-2ca6-460f-a3f6-89bd70e0ef4b.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/637d4da7-1dca-423e-8a1e-77424365e775.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/29b67d33-85b6-4bc2-ae03-e8db06472497.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/17715a3d-114f-43b9-a6f6-114deac16bad.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0170ccc0-c68b-4226-a0bb-646ca4e06272.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/526739/74654526739.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/526739/69846526739.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/526739/68344526739.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/526739/5267390319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/526739/5267390318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/526739/5267390317.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:38:13.128Z.